Spectrin Jendouba: an alpha II/31 spectrin variant that is associated with elliptocytosis and carries a mutation distant from the dimer self-association site. 1992

N Alloisio, and R Wilmotte, and L Morlé, and F Baklouti, and J Maréchal, and M T Ducluzeau, and L Denoroy, and C Féo, and B G Forget, and R Kastally
CNRS URA 1171, Faculté de Médecine Grange-Blanche, Lyon, France.

Spectrin Jendouba (alpha II/31) was found in a Tunisian family. In the heterozygous state, it is associated with asymptomatic elliptocytosis and a minimal defect in spectrin dimer self-association. On partial digestion of spectrin with trypsin, an abnormal cleavage appeared following Lys 788. Peptide and DNA sequencing indicated that the responsible mutation is alpha 791 Asp----Glu (GAC----GAA). As in most alpha-spectrin variants associated with elliptocytosis, the change alters helix 3 of the proposed triple helical model of spectrin structure. Modified helix 3 in repeat alpha 8 is the most distant from the N-terminus of alpha-spectrin in known variants associated with elliptocytosis.

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004612 Elliptocytosis, Hereditary An intrinsic defect of erythrocytes inherited as an autosomal dominant trait. The erythrocytes assume an oval or elliptical shape. Ovalocytosis, Hereditary,Elliptocytoses, Hereditary,Hereditary Elliptocytoses,Hereditary Elliptocytosis,Hereditary Ovalocytoses,Hereditary Ovalocytosis,Ovalocytoses, Hereditary
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons

Related Publications

N Alloisio, and R Wilmotte, and L Morlé, and F Baklouti, and J Maréchal, and M T Ducluzeau, and L Denoroy, and C Féo, and B G Forget, and R Kastally
September 1990, The Journal of clinical investigation,
N Alloisio, and R Wilmotte, and L Morlé, and F Baklouti, and J Maréchal, and M T Ducluzeau, and L Denoroy, and C Féo, and B G Forget, and R Kastally
March 1982, Proceedings of the National Academy of Sciences of the United States of America,
N Alloisio, and R Wilmotte, and L Morlé, and F Baklouti, and J Maréchal, and M T Ducluzeau, and L Denoroy, and C Féo, and B G Forget, and R Kastally
May 1998, The Biochemical journal,
N Alloisio, and R Wilmotte, and L Morlé, and F Baklouti, and J Maréchal, and M T Ducluzeau, and L Denoroy, and C Féo, and B G Forget, and R Kastally
October 1993, Blood,
N Alloisio, and R Wilmotte, and L Morlé, and F Baklouti, and J Maréchal, and M T Ducluzeau, and L Denoroy, and C Féo, and B G Forget, and R Kastally
October 1982, The Journal of clinical investigation,
N Alloisio, and R Wilmotte, and L Morlé, and F Baklouti, and J Maréchal, and M T Ducluzeau, and L Denoroy, and C Féo, and B G Forget, and R Kastally
April 1988, Blood,
N Alloisio, and R Wilmotte, and L Morlé, and F Baklouti, and J Maréchal, and M T Ducluzeau, and L Denoroy, and C Féo, and B G Forget, and R Kastally
June 1983, British journal of haematology,
N Alloisio, and R Wilmotte, and L Morlé, and F Baklouti, and J Maréchal, and M T Ducluzeau, and L Denoroy, and C Féo, and B G Forget, and R Kastally
March 1992, The Journal of clinical investigation,
N Alloisio, and R Wilmotte, and L Morlé, and F Baklouti, and J Maréchal, and M T Ducluzeau, and L Denoroy, and C Féo, and B G Forget, and R Kastally
June 1994, Blood,
N Alloisio, and R Wilmotte, and L Morlé, and F Baklouti, and J Maréchal, and M T Ducluzeau, and L Denoroy, and C Féo, and B G Forget, and R Kastally
August 1992, Blood,
Copied contents to your clipboard!